Clinical Trial: The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting

Press/Media

Period19 Aug 2021

Media coverage

2

Media coverage

  • TitleClinical Trial: The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date19/08/21
    PersonsAshutosh Tewari
  • TitleClinical Trial: The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting
    Media name/outletHealth Daily Digest (Ht Media)
    Country/TerritoryIndia
    Date19/08/21
    PersonsAshutosh Tewari